Company announcement -- No. 2 / 2026
Zealand Pharma convenes its Annual General Meeting 2026
Copenhagen, Denmark, February 19, 2026 -- Zealand Pharma A/S ("the Company" or "Zealand Pharma") (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, hereby convenes its Annual General Meeting 2026.
The Board of Directors of Zealand Pharma A/S hereby convenes the Annual General Meeting of the Company to be held on:
Thursday, 26 March 2026 at 03:00 PM $(CET)$ / 9:00 $(ET)$
The Annual General Meeting will be held as a partly electronic general meeting (hybrid meeting), allowing shareholders to participate either electronically or in person.
The meeting will be conducted electronically via the virtual meeting portal hosted by Computershare A/S, and physically at the Company's registered office at Sydmarken 11, DK--2860 Søborg, Denmark.
Further information, including the agenda and practical details regarding participation and voting, is set out in the accompanying materials.
# # #
About Zealand Pharma
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data--driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health.
To date, more than ten Zealand Pharma--invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization.
Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.
Contacts
Adam Lange (Investors)
Vice President, Investor Relations
Zealand Pharma
Email: alange@zealandpharma.com
Neshat Ahmadi (Investors)
Investor Relations Manager
Zealand Pharma
Email: neahmadi@zealandpharma.com
Rachel James-Owens (Media)
Vice President, Corporate Communications & Media Relations
Zealand Pharma
RJamesOwens@zealandpharma.com
Attachment
-- Zealand Pharma - AGM 2026 Notice
(END) Dow Jones Newswires
February 19, 2026 08:00 ET (13:00 GMT)